ADIPOQ and atherosclerosis: Furthermore, adiponectin effectively inhibits the activation of the NF-κB pathway by suppressing the expression of the NF-κB nuclear protein p65, which, in turn, reduces the expression of NF-κB-regulated pro-inflammatory factors and potently attenuates the inflammatory response to atherosclerosis (Wang et al., 2016).